SRMS

Tyrosine-protein kinase Srms UniProt accession Q9H3Y6

Non-receptor tyrosine-protein kinase which phosphorylates DOK1 on tyrosine residues (PubMed:23822091). Also phosphorylates KHDRBS1/SAM68 and VIM on tyrosine residues (PubMed:29496907). Phosphorylation of KHDRBS1 is EGF-dependent (PubMed:29496907).

Phosphorylates OTUB1, promoting deubiquitination of RPTOR (PubMed:35927303)

Source: UniProt

Interacts (via the SH2 and SH3 domains) with DOK1 (PubMed:23822091). Interacts with KHDRBS1/SAM68 and VIM (PubMed:29496907)

Source: UniProt
Cytoplasm
Source: UniProt

Highly expressed in most breast cancers (at protein level)

Source: UniProt

The N-terminal region regulates its kinase activity

Source: UniProt
  • PTK6 Down-Regulation
Source: Reactome via UniProt

Mutations

No mutation information available.

Synthetic Lethal Network

Genes with an experimentally identified or computationally predicted synthetic-lethal relationship to SRMS, aggregated across our SSL data sources. Click any partner node to view that gene’s page.

Nodes and edges are coloured by the SSL data source. Partners appearing in more than one source are shown in grey.

BioGRID SLOrth SynLethDB MexDrugs Multi-source
Sources: BioGRID, SLOrth, SynLethDB, MexDrugs

Clinical Trials

Total Trials Found: 2

NCT ID Condition Brief Title Phase Status
NCT02828709 Kidney Cancer Safety and Feasibility of IRE for SRMs PHASE2 UNKNOWN
NCT03804320 Kidney Cancer Protocol Active Surveillance Small Renal Masses (SRMs) NA RECRUITING